Regulatory Story
Go to market news section View chart   Print
Eden Research plc  -  EDEN   

Posting of Annual Report & Notice of AGM

Released 10:46 06-Jun-2014

RNS Number : 0381J
Eden Research plc
06 June 2014


Eden Research Plc

("Eden" or "Company")


Posting of Annual Report & Notice of AGM


Eden Research plc (AIM: EDEN), the AIM listed natural micro-encapsulation company, confirms that the Annual Report and Accounts for the year ended 31 December 2013 ("2013 Annual Report and Accounts"), the Notice of the Annual General Meeting ("AGM") and a Form of Proxy were posted to shareholders on 4 June 2014.


The AGM is to be held at 12 noon on 26 June 2014 at The Four Pillars Hotel, Ducklington Lane, Witney OX28 4EX.


A copy of the 2013 Annual Report and Accounts and other documents are available on the Company's website.



Eden Research plc  

Clive Newitt, Managing Director

Tel: 01993 862 761

Alex Abrey, Chief Financial Officer

W H Ireland Limited      

Tel: 0117 945 3471

John Wakefield

Walbrook PR Ltd

Tel: 020 7933 8780 or

Paul McManus

Mob: 07980 541 893




Eden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products.


Eden's encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with hydrophobic compounds both natural and synthetic. The technology uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.


Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.


With leading consultants in their respective fields, the Company is developing these technologies through innovative research and a series of commercial production, marketing and distribution partnerships.


The Company has a number of patents and has a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. To date, the Company has invested in the region of £12m in developing and protecting its intellectual property. Revenues earned by the Company have been modest whilst the Company has concentrated on securing patent protection for its intellectual property, identifying suitable industrial partners and entering into licence agreements.


Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN.


For more information about Eden, please visit 


This information is provided by RNS
The company news service from the London Stock Exchange

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


Posting of Annual Report & Notice of AGM - RNS